VanEck Biotech ETF (NASDAQ:BBH) Sees Large Volume Increase – What’s Next?

Shares of VanEck Biotech ETF (NASDAQ:BBH) saw unusually-high trading volume on Thursday. Approximately 9,163 shares were traded during mid-day trading, an increase of 14% from the average daily volume of 8,052 shares. The stock last traded at $256.0260 and had previously closed at $257.79.

VanEck Biotech ETF Price Performance

The company has a 50 day moving average price of $243.61 and a 200 day moving average price of $209.27.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Global Retirement Partners LLC bought a new position in VanEck Biotech ETF in the third quarter valued at approximately $41,000. HighTower Advisors LLC bought a new stake in shares of VanEck Biotech ETF during the third quarter worth $1,124,000. Harbour Investments Inc. acquired a new stake in shares of VanEck Biotech ETF during the third quarter worth $38,000. IFG Advisory LLC acquired a new stake in shares of VanEck Biotech ETF during the third quarter worth $124,000. Finally, Allworth Financial LP bought a new stake in VanEck Biotech ETF in the 3rd quarter valued at $104,000. Institutional investors own 32.05% of the company’s stock.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.